Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henrik Vestergaard

Showing results (61-70 of 133) with videos related to

Pageof 14
Sort By:
Frontiers in Clinical Diabetes and Healthcare|March 30, 2023
Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A <i>Post Hoc</i> Analysis of the LIRAFLAME Randomized Placebo-Controlled TrialAsger Wretlind, Emilie Hein Zobel, Andressa de Zawadzki, et al.
Obesity (Silver Spring, Md.)|February 15, 2018
Prospective Studies Exploring the Possible Impact of an ID3 Polymorphism on Changes in Obesity MeasuresMathilde Svendstrup, Emil V R Appel, Camilla H Sandholt, et al.
Cell Reports. Medicine|November 11, 2025
Glucocorticoid-induced changes of the gut microbiota and metabolic markers in healthy young men: Outcome of a randomized controlled trialLiwei Lyu, Yong Fan, Thomas Bryrup, et al.
Scientific Reports|April 9, 2024
Characterization of the gut bacterial and viral microbiota in latent autoimmune diabetes in adultsCasper S Poulsen, Dan Hesse, Gabriel R Fernandes, et al.
Lipids in Health and Disease|September 26, 2023
Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trialsAsger Wretlind, Viktor Rotbain Curovic, Andressa de Zawadzki, et al.
Plos One|May 28, 2021
Genetic markers of abdominal obesity and weight loss after gastric bypass surgeryMartin Aasbrenn, Mathilde Svendstrup, Theresia M Schnurr, et al.
Contemporary Clinical Trials Communications|March 16, 2023
Quality of life, patient satisfaction, and cardiovascular outcomes of the randomised 2 x 3 factorial Copenhagen insulin and Metformin therapy (CIMT) trial - A detailed statistical analysis planMarkus Harboe Olsen, Thomas P Almdal, Sten Madsbad, et al.
Frontiers in Cellular and Infection Microbiology|November 16, 2020
Comparative Studies of the Gut Microbiota in the Offspring of Mothers With and Without Gestational DiabetesMie Korslund Wiinblad Crusell, Tue Haldor Hansen, Trine Nielsen, et al.
BMC Genetics|March 18, 2018
Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responsesLine Engelbrechtsen, Yuvaraj Mahendran, Anna Jonsson, et al.
Microbiome|May 17, 2018
Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartumMie Korslund Wiinblad Crusell, Tue Haldor Hansen, Trine Nielsen, et al.
Pageof 14

Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
Frontiers in Clinical Diabetes and Healthcare|March 30, 2023
Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A <i>Post Hoc</i> Analysis of the LIRAFLAME Randomized Placebo-Controlled TrialAsger Wretlind, Emilie Hein Zobel, Andressa de Zawadzki, et al.
Obesity (Silver Spring, Md.)|February 15, 2018
Prospective Studies Exploring the Possible Impact of an ID3 Polymorphism on Changes in Obesity MeasuresMathilde Svendstrup, Emil V R Appel, Camilla H Sandholt, et al.
Cell Reports. Medicine|November 11, 2025
Glucocorticoid-induced changes of the gut microbiota and metabolic markers in healthy young men: Outcome of a randomized controlled trialLiwei Lyu, Yong Fan, Thomas Bryrup, et al.
Scientific Reports|April 9, 2024
Characterization of the gut bacterial and viral microbiota in latent autoimmune diabetes in adultsCasper S Poulsen, Dan Hesse, Gabriel R Fernandes, et al.
Lipids in Health and Disease|September 26, 2023
Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trialsAsger Wretlind, Viktor Rotbain Curovic, Andressa de Zawadzki, et al.
Plos One|May 28, 2021
Genetic markers of abdominal obesity and weight loss after gastric bypass surgeryMartin Aasbrenn, Mathilde Svendstrup, Theresia M Schnurr, et al.
Contemporary Clinical Trials Communications|March 16, 2023
Quality of life, patient satisfaction, and cardiovascular outcomes of the randomised 2 x 3 factorial Copenhagen insulin and Metformin therapy (CIMT) trial - A detailed statistical analysis planMarkus Harboe Olsen, Thomas P Almdal, Sten Madsbad, et al.
Frontiers in Cellular and Infection Microbiology|November 16, 2020
Comparative Studies of the Gut Microbiota in the Offspring of Mothers With and Without Gestational DiabetesMie Korslund Wiinblad Crusell, Tue Haldor Hansen, Trine Nielsen, et al.
BMC Genetics|March 18, 2018
Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responsesLine Engelbrechtsen, Yuvaraj Mahendran, Anna Jonsson, et al.
Microbiome|May 17, 2018
Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartumMie Korslund Wiinblad Crusell, Tue Haldor Hansen, Trine Nielsen, et al.
Pageof 14